Thrive — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Isomorphic Labsisomorphiclabs.comin𝕏Apr 2025
Isomorphic Labs applies artificial intelligence to drug discovery, working to develop treatments for serious diseases.
AI & Machine LearningBiotechDigital HealthHealthtech
Demis Hassabis(Founder)in
Co-investorsCapitalGGV (Google Ventures)AlphabetMGXTemasekThrive Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.